Ischemic Stroke in Patients with Percutaneous Patent Foramen Ovale Closure

Fuente: Redalyc
Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: ALEJANDRO E. CONTRERAS
Format: Artículo científico
Sprache:en
Veröffentlicht: Sociedad Argentina de Cardiología 2017
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1876441134276804608
author ALEJANDRO E. CONTRERAS
author_facet ALEJANDRO E. CONTRERAS
contents Ischemic Stroke in Patients with Percutaneous Patent Foramen Ovale Closure ALEJANDRO E. CONTRERAS MATÍAS MARTÍNEZ ADOLFO FERRERO GUADAGNOLI JONATHAN MIARA LÓPEZ ALEJANDRO R. PEIRONE Medicina Patent Stroke Atrial surgery Foramen Ovale Background: The prevalence of patent foramen ovale is approximately 50% in patients who have suffered a cryptogenic stroke. The recurrence of ischemic stroke after percutaneous patent foramen ovale closure is approximately 1% per year. Objective: The aim of this study was to evaluate the prevalence of recurrent ischemic stroke in our population undergoing percutaneous patent foramen ovale closure. Methods: All patients with diagnosis of cryptogenic ischemic stroke who underwent percutaneous patent foramen ovale closure between January 2007 and September 2015 were retrospectively included. Follow-up detected patients who had either a recurrent stroke and/or a transient ischemic attack after percutaneous patent foramen ovale closure. Results: Twenty eight patients with average age of 47 years (20-71 years) at the time of the procedure were included in the study. Fifty percent of patients were females, 79% had previous history of stroke and 21% of transient ischemic attack. The RoPE score was 7.07 points (3-10 points) and percutaneous closure was successful in all cases. During follow-up (median 989 days, interquartile range 670-1766 days), two patients (7%) had a new stroke. In both patients, transesophageal echocardiography revealed closed patent foramen ovale without residual leak. Conclusions: The incidence of a recurrent stroke is low after percutaneous patent foramen ovale closure and it is possible that a significant number of recurrent cases will not be preventable with its closure. 2017 artículo científico 0034-7000 https://www.redalyc.org/articulo.oa?id=305353231007 en http://www.redalyc.org/revista.oa?id=3053 Revista Argentina de Cardiología application/pdf Sociedad Argentina de Cardiología Revista Argentina de Cardiología (Argentina) Num.3 Vol.85
format Artículo científico
id redalyc_305353231007
institution Redalyc
language en
publishDate 2017
publisher Sociedad Argentina de Cardiología
spellingShingle Ischemic Stroke in Patients with Percutaneous Patent Foramen Ovale Closure
ALEJANDRO E. CONTRERAS
Medicina
Patent
Stroke
Atrial
surgery
Foramen Ovale
Ischemic Stroke in Patients with Percutaneous Patent Foramen Ovale Closure ALEJANDRO E. CONTRERAS MATÍAS MARTÍNEZ ADOLFO FERRERO GUADAGNOLI JONATHAN MIARA LÓPEZ ALEJANDRO R. PEIRONE Medicina Patent Stroke Atrial surgery Foramen Ovale Background: The prevalence of patent foramen ovale is approximately 50% in patients who have suffered a cryptogenic stroke. The recurrence of ischemic stroke after percutaneous patent foramen ovale closure is approximately 1% per year. Objective: The aim of this study was to evaluate the prevalence of recurrent ischemic stroke in our population undergoing percutaneous patent foramen ovale closure. Methods: All patients with diagnosis of cryptogenic ischemic stroke who underwent percutaneous patent foramen ovale closure between January 2007 and September 2015 were retrospectively included. Follow-up detected patients who had either a recurrent stroke and/or a transient ischemic attack after percutaneous patent foramen ovale closure. Results: Twenty eight patients with average age of 47 years (20-71 years) at the time of the procedure were included in the study. Fifty percent of patients were females, 79% had previous history of stroke and 21% of transient ischemic attack. The RoPE score was 7.07 points (3-10 points) and percutaneous closure was successful in all cases. During follow-up (median 989 days, interquartile range 670-1766 days), two patients (7%) had a new stroke. In both patients, transesophageal echocardiography revealed closed patent foramen ovale without residual leak. Conclusions: The incidence of a recurrent stroke is low after percutaneous patent foramen ovale closure and it is possible that a significant number of recurrent cases will not be preventable with its closure. 2017 artículo científico 0034-7000 https://www.redalyc.org/articulo.oa?id=305353231007 en http://www.redalyc.org/revista.oa?id=3053 Revista Argentina de Cardiología application/pdf Sociedad Argentina de Cardiología Revista Argentina de Cardiología (Argentina) Num.3 Vol.85
title Ischemic Stroke in Patients with Percutaneous Patent Foramen Ovale Closure
topic Medicina
Patent
Stroke
Atrial
surgery
Foramen Ovale
url https://www.redalyc.org/articulo.oa?id=305353231007